组织学亚型对肾细胞癌术后复发的影响:RECUR联盟研究
该多中心回顾性研究纳入2006至2011年间15个中心手术治疗的3331例非转移性肾细胞癌患者,分析组织学亚型对复发率、复发时间及复发模式的影响。结果显示透明细胞癌5年无复发生存率显著低于乳头状癌和嫌色细胞癌(78% vs 86% vs 91%),且各亚型复发部位和动态不同,提示随访策略应结合亚型和风险评分制定。
要点
- 透明细胞癌5年无复发生存率显著低于乳头状癌和嫌色细胞癌。
- 中高危乳头状癌淋巴结复发率增加,需关注纵隔和腹膜后。
- 嫌色细胞癌复发罕见,多与高分期和切缘阳性相关。
核心结论
- 肾细胞癌主要组织学亚型具有不同的复发模式和动态。
- 中高危乳头状癌可能受益于术后每6个月腹部横断面成像至2年。
- 嫌色细胞癌除晚期或切缘阳性外可放弃常规影像随访。
研究设计与样本
- 共3331例患者,62.2%行根治性肾切除术,37.8%行部分肾切除术。
主要发现
- 透明细胞癌2565例(77.0%),乳头状癌535例(16.1%),嫌色细胞癌231例(6.9%)。
- 中位术后随访61.7个月(四分位距47-83)。
- 透明细胞癌5年无复发生存率78%,乳头状癌86%,嫌色细胞癌91%(p=0.001)。
- 透明细胞癌最常见复发部位为肺和骨。
- 嫌色细胞癌复发率8.2%,主要位于肝和骨,与高分期和切缘阳性相关。
关键数值与推荐
- 中高危乳头状癌患者可考虑术后每6个月腹部横断面成像直至2年。
- 嫌色细胞癌患者除晚期或切缘阳性外,可放弃常规影像随访。
临床怎么用
- 随访策略应根据组织学亚型和风险评分个体化制定。
- 透明细胞癌需重点监测肺和骨复发。
- 中高危乳头状癌应加强腹部影像监测淋巴结复发。
- 嫌色细胞癌可减少常规影像检查,但晚期或切缘阳性者仍需腹部CT。
局限性
- 研究为回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current follow-up strategies for patients with renal cell carcinoma (RCC) after curative surgery rely mainly on risk models and the treatment delivered, regardless of the histological subtype. OBJECTIVE: To determine the impact of RCC histological subtype on recurrence and to examine the incidence, pattern, and timing of recurrences to improve follow-up recommendations. DESIGN, SETTING, AND PARTICIPANTS: This study included consecutive patients treated surgically with curative intention (ie, radical and partial nephrectomy) for nonmetastatic RCC (cT1-4, M0) between January 2006 and December 2011 across 15 centres from 10 countries, as part of the euRopEan association of urology renal cell carcinoma guidelines panel Collaborative multicenter consortium for the studies of follow-Up and recurrence patterns in Radically treated renal cell carcinoma patients (RECUR) database project. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The impact of histological subtype (ie, clear cell RCC [ccRCC], papillary RCC [pRCC], and chromophobe RCC [chRCC]) on recurrence-free survival (RFS) was assessed via univariate and multivariate analyses, adjusting for potential interactions with important variables (stage, grade, risk score, etc.) Patterns of recurrence for all histological subtypes were compared according to recurrence site and risk criteria. RESULTS AND LIMITATIONS: Of the 3331 patients, 62.2% underwent radical nephrectomy and 37.8% partial nephrectomy. A total of 2565 patients (77.0%) had ccRCC, 535 (16.1%) had pRCC, and 231 (6.9%) had chRCC. The median postoperative follow-up period was 61.7 (interquartile range: 47-83) mo. Patients with ccRCC had significantly poorer 5-yr RFS than patients with pRCC and chRCC (78% vs 86% vs 91%, p = 0.001). The most common sites of recurrence for ccRCC were the lung and bone. Intermediate-/high-risk pRCC patients had an increased rate of lymphatic recurrence, both mediastinal and retroperitoneal, while recurrence in chRCC was rare (8.2%), associated with higher stage and positive margins, and predominantly in the liver and bone. Limitations include the retrospective nature of the study. CONCLUSIONS: The main histological subtypes of RCC exhibit a distinct pattern and dynamics of recurrence. Results suggest that intermediate- to high-risk pRCC may benefit from cross-sectional abdominal imaging every 6 mo until 2 yr after surgery, while routine imaging might be abandoned for chRCC except for abdominal computed tomography in patients with advanced tumour stage or positive margins. PATIENT SUMMARY: In this analysis of a large database from 15 countries around Europe, we found that the main histological subtypes of renal cell carcinoma have a distinct pattern and dynamics of recurrence. Patients should be followed differently according to subtype and risk score.
引用
- Abu-Ghanem Y, Powles T, Capitanio U, et al. The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium. Eur Urol Oncol. 2020. PMID: 33109495. doi:10.1016/j.euo.2020.09.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。